TITLE

New perspectives on basic mechanisms in lung disease. 3. Drug intervention in asthma: present and future

AUTHOR(S)
Alabaster, V A; Moore, B A
PUB. DATE
February 1993
SOURCE
Thorax;Feb1993, Vol. 48 Issue 2, p176
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
No abstract available.
ACCESSION #
66023929

 

Related Articles

  • New drugs targeting Th2 lymphocytes in asthma. Caramori, Gaetano; Groneberg, David; Ito, Kazuhiro; Casolari, Paolo; Adcock, Ian M.; Papi, Alberto // Journal of Occupational Medicine & Toxicology;2008, Vol. 3, Special section p1 

    Asthma represents a profound worldwide public health problem. The most effective anti-asthmatic drugs currently available include inhaled β2-agonists and glucocorticoids and control asthma in about 90-95% of patients. The current asthma therapies are not cures and symptoms return soon after...

  • Editorial [Guest Editor: Strategies for the Improvement of Asthma Therapy (Executive Editor: Andreas Pahl)]. Pahl, Andreas // Current Pharmaceutical Design;Sep2006, Vol. 12 Issue 25, p3173 

    Asthma bronchiale, affecting 155 millions people worldwide, has emerged as a major public health problem worldwide over the past 20 years. Although data indicate that current asthma therapies led to limited decreases in death rates, it continues to be a significant health care problem. As we...

  • Mechanisms of Remodeling in Asthmatic Airways. Shifren, Adrian; Witt, Chad; Christie, Chandrika; Castro, Mario // Journal of Allergy;2012, p1 

    Asthma is a chronic inflammatory airway disorder characterized by airway hyperresponsiveness and reversible airflow obstruction. Subgroups of asthma patients develop airflow obstruction that is irreversible or only partially reversible and experience an accelerated rate of lung function decline....

  • Drug Watch. Lung diseases (COPD and asthma).  // Formulary;Oct2011, Vol. 46 Issue 10, p452 

    A chart is presented which lists information on several drugs, including Aclidinium, vilanterol and Flutiform, which are being developed in 2011 to treat lung diseases, including asthma and chronic obstructive pulmonary disease.

  • Die Zukunft der Depressionsforschung. Holsboer, F. // Der Nervenarzt;Nov2010, Vol. 81 Issue 11, p1306 

    in the past, future depression research will be oriented to the genetics and pharmacology of antidepressants as well as molecular and clinical biomarkers. Using new technologies patient populations with practically equal disease mechanisms will be identified which can be specifically treated...

  • Obstructive lung diseases and inhaler treatment: results from a national public pragmatic survey. Braido, Fulvio; Baiardini, Ilaria; Sumberesi, Massimo; Blasi, Francesco; Canonica, Giorgio Walter // Respiratory Research;Sep2013, Vol. 14 Issue 9, p1 

    Background: The opinions held by the general population on obstructive lung disease and inhaler devices could influence asthma and chronic obstructive pulmonary disorder (COPD) management and treatment adherence. The aim of the present public pragmatic survey was to evaluate the opinions,...

  • Helping New York breathe a little easier. Cerini, Kenneth R. // Long Island Business News (7/1993 to 5/2009);4/6/2007, Vol. 54 Issue 15, p36A 

    An interview with Deborah Carioto, president of the American Lung Association (ALA) in New York, is presented. When asked about the overall mission of her organization, she asserts that their mission is the promotion of lung health and the prevention of lung disease. Carioto explains the major...

  • Preface. Ajay Gautam // Current Cancer Drug Targets;Aug2003, Vol. 3 Issue 4, p1 

    Aerosol delivery of drugs holds promise for a number of diseases. The large blood vessel network feeding the lungs make them accessible from the intravenous route, and the endothelium and lung parenchyma have been targeted intravenously for a number of drugs. However, the easy access of the...

  • The influence of obesity on inflammation and clinical symptoms in asthma. Gruchała-Niedoszytko, M.; Małgorzewicz, S.; Niedoszytko, M.; Gnacińska, M.; Jassem, E. // Advances in Medical Sciences (De Gruyter Open);2013, Vol. 58 Issue 1, p15 

    Obesity and asthma are both important public health issues. Increasing number of studies suggest the association between obesity and asthma which may be causal or accidental. The studies on animal models show innate enhancement of airway hyper-responsiveness which suggest that chronic airway...

  • Patient counseling improves asthma care. Tanzi, Maria G. // Pharmacy Today;Dec2009, Vol. 15 Issue 12, p15 

    The article informs that patient counseling can actually improve asthma care for patients. It is stated that the most recent asthma guidelines recommended by the National Heart, Lung, and Blood Institute in the U.S., include educational interventions by pharmacists to enhance asthma management....

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics